Nine Nations Agree to Build Synchrotron

LONDON—Europe has decided to remain at the forefront of condensed matter research with an agreement by nine countries to start building the $500 million European Synchrotron Radiation Facility (ESRF) next year in Grenoble, France. At the same time, the United Kingdom has bolstered its reputation for remaining out of step with the rest of European science by refusing to pledge its support for the ESRF at a key meeting last month. Although the British Science and Engineering Research Cou

Written byJon Turney
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

LONDON—Europe has decided to remain at the forefront of condensed matter research with an agreement by nine countries to start building the $500 million European Synchrotron Radiation Facility (ESRF) next year in Grenoble, France.

At the same time, the United Kingdom has bolstered its reputation for remaining out of step with the rest of European science by refusing to pledge its support for the ESRF at a key meeting last month. Although the British Science and Engineering Research Council has helped to plan the new machine since it was proposed a decade ago, it cannot by itself raise sufficient funds to provide the 15 percent expected by its partners.

Ironically, Britain already operates the leading X-ray machine, SERC’s Synchrotron Radiation Source, at the Daresbury Laboratory in Cheshire. The machine has been upgraded recently to increase its brightness, and ESRF is regarded as its successor. The two will be complementary, with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies